BIO 2016 : DIATHEVA presents “scFv 2G8” monoclonal antibody a new approach to fungal infections
DIATHEVA presented a new product in pipeline "scFv 2G8" [...]
New pubblication Diatheva’s pipeline antibody therapeutics
Diatheva’s pipeline antibody-based therapies is designated to address significant unmet [...]
The new Italian guideline for the prevention and control of Legionellosis were approved
New Italian guidelines for the prevention and control of legionellosis [...]
Detection and quantification of Legionella spp
It’s spring , the right time for monitoring Legionella spp. [...]
DIATHEVA , partner in the co-development of a recombinant antibody for the treatment of Ewing Sarcoma
A recent paper published in the prestigious scientific journal Clinical [...]